Enfuvirtide (CAT#: TP-099CL)

Enfuvirtide is a 36 residue synthetic peptide that inhibits HIV-1 fusion with CD4 cells. It is an N-terminal acetylated, C-terminal amide. As an HIV fusion inhibitor, it is the first of a novel class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection.


  • Datasheet
  • MSDS
  • COA

Specifications

  • Classify
  • Protein therapeutics that interfere with a molecule or organism: Infectious diseases
  • Therapeutic
  • Enfuvirtide
  • Trade Name
  • Fuzeon
  • Function
  • 36 amino-acid peptide that inhibits Hiv entry into host cells by binding to the Hiv envelope protein gp120/gp41
  • Examples of clinical use
  • Adults and children (at least 6 years old) with advanced Hiv infection

References

  • Synonyms
  • Envelope polyprotein GP160 precursor [Contains: Exterior membrane glycoprotein,GP120, Transmembrane glycoprotein,GP41]
  • UniProt
  • Q70626
  • Genbank
  • U12055

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "env"

Immunotoxin

CAT Product Name Application Type
AGTO-L012R anti-env immunotoxin 907 (IgG)-RTA Cytotoxicity assay, Functional assay

Single-domain Antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TP-099CL. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare